Article

Wavefront-optimized treatment helps irregular corneas

An excimer laser system (Allegretto Wave Eye-Q, WaveLight Inc.), which offers a 400 Hz ablation rate, can safely correct corneal irregularities, such as those seen in patients previously treated with small optical zones or decentered ablations. The system also can correct primary astigmatism and has been used in eyes with keratoconus awaiting corneal transplant, explained David T. Lin, MD, at a breakfast session sponsored by WaveLight during the American Society of Cataract and Refractive Surgery meeting.

An excimer laser system (Allegretto Wave Eye-Q, WaveLight Inc.), which offers a 400 Hz ablation rate, can safely correct corneal irregularities, such as those seen in patients previously treated with small optical zones or decentered ablations. The system also can correct primary astigmatism and has been used in eyes with keratoconus awaiting corneal transplant, explained David T. Lin, MD, at a breakfast session sponsored by WaveLight.

Dr. Lin, of Vancouver, British Columbia, described several cases in which topographic-guided vision correction with this system was useful. He showed the optical zone enlargement of a patient who had been previously treated with four RK incisions. In another case, a patient with asymmetrical astigmatism after a wavefront-guided procedure had improvement in vision after the topographic-guided treatment. Decentered ablations were re-treated with the excimer laser system in 34 eyes and only one patient lost 1 line of best-corrected visual acuity.

In the keratoconus cases, 16 eyes awaiting corneal transplant were treated with transepithelial topographic-guided PRK with the excimer laser system, selectively treating the steep area and steepening the flat area. Little haze occurred, Dr. Lin said.

During the session, other presentations from users included patient flow, enhancement, and clinical realities by Anthony J. Kameen, MD, Baltimore; successful cyclotorsion control with Neuro Track (not available in the United States) by Arthur Cummings, MD, Dublin, Ireland; global optimum: presbyopia treatments by Theo Seiler, MD, PhD, Zurich, Switzerland; and the Allegro Oculyzer (WaveLight) in practice (not available in the United States) by Matthias J. Maus, MD, Cologne, Germany.

Topographic-guided treatment works on irregular corneas such as in eyes that have undergone PRK, LASIK, and post-RK, he said. It can be used to treat primary astigmatism, optical zone enlargements, and decentered ablations.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.